Illumina Earnings, Revenue Miss in Q2
2022.08.11 23:18
Illumina Earnings, Revenue Miss in Q2
Investing.com – Illumina (NASDAQ:ILMN) reported on Thursday second quarter earnings that missed analysts’ forecasts and revenue that fell short of expectations.
Illumina announced earnings per share of $0.57 on revenue of $1.16B. Analysts polled by Investing.com anticipated EPS of $0.6389 on revenue of $1.22B.
Illumina shares are down 40.22% from the beginning of the year, still down 56.76% from its 52 week high of $526.00 set on August 16, 2021. They are under-performing the Nasdaq 100 which is down 18.55% from the start of the year.
Illumina shares lost 17.78% in after-hours trade following the report.
Illumina follows other major Healthcare sector earnings this month
Illumina’s report follows an earnings beat by UnitedHealth on July 15, who reported EPS of $5.57 on revenue of $80.33B, compared to forecasts EPS of $5.21 on revenue of $79.68B.
J&J had beat expectations on July 19 with second quarter EPS of $2.59 on revenue of $24.02B, compared to forecast for EPS of $2.54 on revenue of $23.77B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
